New hope for kids with rare blood diseases: safer transplant trial begins
NCT ID NCT04806347
Summary
This early-stage trial is testing a modified stem cell transplant for children and young adults with serious, non-cancerous blood diseases like sickle cell anemia and bone marrow failure syndromes. The goal is to make the transplant safer by using a new method to filter the donor cells, aiming to reduce dangerous complications while keeping helpful immune cells. Researchers will enroll 12 patients to see if this approach is safe and feasible.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLOOD DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.